---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-076526"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2026-07-09T10:08:49+00:00"
generated_at: "2026-07-09T10:10:04.534048+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ENDRA Life Sciences regains Nasdaq compliance; subject to one-year monitor

## Summary
- Nasdaq notified ENDRA on July 8, 2026 that it regained compliance with the $2.5M Minimum Stockholders' Equity Requirement.
- Company had been below requirement; requested hearing on April 27, 2026, hearing held May 28, 2026.
- Subject to Discretionary Panel Monitor for one year from July 1, 2026.
- If non-compliant again during monitor period, no cure period; immediate delisting process begins.
- Company can request a new hearing if a delisting determination is issued.

## SEC filing metadata
- accession: 0001213900-26-076526
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2026-07-09T10:08:49+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000121390026076526/0001213900-26-076526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000121390026076526/ea0297455-8k_endra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-076526
- JSON: https://secwatch.observer/filing/0001213900-26-076526.json
- Plain text: https://secwatch.observer/filing/0001213900-26-076526.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.